CXCL8 also recruits MDSCs that inhibit anti-tumor T cell function via the induction of Tregs and production of immunosuppressive cytokines including IL-10 and transforming growth factor beta (TGF-β) [27]. The gene discussed is CXCL8; the disease is neoplasm.